Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-036847
Filing Date
2020-06-15
Accepted
2020-06-15 21:13:11
Documents
1
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5763
  Complete submission text file 0001209191-20-036847.txt   7058
Mailing Address 179 SANDY POND ROAD LINCOLN MA 01773
Business Address
ROCKLAGE SCOTT M (Reporting) CIK: 0001219014 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 20964786

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations